Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment

The patient population suffering from pancreatic ductal adenocarcinoma (PDAC) presents, as a whole, with a high degree of molecular tumor heterogeneity. The heterogeneity of PDAC tumor composition has complicated treatment and stalled success in clinical trials. Current in vitro techniques insuffici...

Descripción completa

Detalles Bibliográficos
Autores principales: Haque, Muhammad R., Wessel, Caitlin R., Leary, Daniel D., Wang, Chengyao, Bhushan, Abhinav, Bishehsari, Faraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971446/
https://www.ncbi.nlm.nih.gov/pubmed/35450328
http://dx.doi.org/10.1038/s41378-022-00370-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971446/
https://www.ncbi.nlm.nih.gov/pubmed/35450328
http://dx.doi.org/10.1038/s41378-022-00370-6

Ejemplares similares